RT期刊文章SR电子T1广泛耐药结核的流行病学和临床管理:系统回顾了TBNET摩根富林明欧洲呼吸杂志乔和J FD欧洲呼吸学会SP 871欧元OP 881做10.1183/09031936.00168008 VO 33 A1是4 g . Sotgiu A1 g·费拉拉A1。188bet官网地址Matteelli A1 m·d·理查森A1 r .好像A1 s Ruesch-Gerdes A1 o Toungoussova A1 j]。齐薇格A1。Spanevello A1 d Cirillo A1 c·兰格A1 g . b . Migliori年2009 UL //www.qdcxjkg.com/content/33/4/871.abstract AB广泛耐药结核病(xdr - tb)是存在于所有区域和公共卫生和临床管理带来了严峻挑战。实验室诊断是困难的和小证据有效指导临床医生在治疗患有广泛耐药结核。在诊断和治疗总结可用数据,当前作者13日进行了系统回顾最近的研究广泛耐药结核的流行病学和临床管理。综述了符合入选标准的研究,为了评估方法、治疗方案和治疗结果。荟萃分析的当前可用的数据是不可能的,因为不一致的定义和方法。广泛耐药结核数据显示,高达65%的患者是可以治愈的,尤其是那些不感染了艾滋病病毒。然而,治疗持续时间更长和成果总体上不如non-XDR结核病患者。 To strengthen the evidence for extensively drug-resistant tuberculosis diagnosis, treatment and prevention, future studies should: 1) be prospective in design; 2) adopt standardised, internationally accepted definitions; 3) use quality-assured laboratory testing for all first- and second-line drugs; and 4) collect data on an agreed-upon set of standard variables, allowing for comparisons across studies. Early diagnosis and aggressive management of extensively drug-resistant tuberculosis provide the best chance of positive outcome, but prevention is still paramount.